Literature DB >> 31003931

Cell Death and Inflammation - A Vital but Dangerous Liaison.

Nieves Peltzer1, Henning Walczak2.   

Abstract

The immune system has developed multiple ways to fight infection. Yet, it is constantly tasked with overcoming newly developing pathogenic mechanisms of resistance to host immunity. In most mammals, the stimulation of both innate and adaptive immune receptors can result in gene activation and cell death induction by apoptosis and necroptosis. RIPK1 and RIPK3 are key mediators of necroptosis; however, new findings support their role in the regulation of cell death-independent proinflammatory signaling. We discuss here the biological functions of RIPK1 and RIPK3, how they regulate cell death and inflammation, and the interplay between them. Finally, we discuss recent advances in our knowledge of linear ubiquitination which, alongside RIPK3 and caspase-8, exerts regulatory functions on RIPK1-mediated inflammation. Together, this review examines the complex interplay between RIPK1, RIPK3, and LUBAC that is important in regulating cell death and inflammatory signaling.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31003931     DOI: 10.1016/j.it.2019.03.006

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  29 in total

1.  Caspases in Cell Death, Inflammation, and Pyroptosis.

Authors:  Sannula Kesavardhana; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  Annu Rev Immunol       Date:  2020-02-04       Impact factor: 28.527

2.  Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice.

Authors:  María José Soler; Marta Riera; Heleia Roca-Ho; Vanesa Palau; Javier Gimeno; Julio Pascual
Journal:  Lab Invest       Date:  2020-05-29       Impact factor: 5.662

3.  Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.

Authors:  Cathelijn E M Aarts; Ida H Hiemstra; Eelke P Béguin; Arjan J Hoogendijk; Souhailla Bouchmal; Michel van Houdt; Anton T J Tool; Erik Mul; Machiel H Jansen; Hans Janssen; Floris P J van Alphen; Jan-Paul de Boer; Charlotte L Zuur; Alexander B Meijer; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood Adv       Date:  2019-11-26

Review 4.  Toll-like receptors in mediating pathogenesis in systemic sclerosis.

Authors:  L Frasca; R Lande
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

Review 5.  Death Receptors and Their Ligands in Inflammatory Disease and Cancer.

Authors:  Alessandro Annibaldi; Henning Walczak
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-09-01       Impact factor: 9.708

6.  Dual roles for LUBAC signaling in thymic epithelial cell development and survival.

Authors:  Reema Jain; Kelin Zhao; Julie M Sheridan; Melanie Heinlein; Fiona Kupresanin; Waruni Abeysekera; Cathrine Hall; James Rickard; Philippe Bouillet; Henning Walczak; Andreas Strasser; John Silke; Daniel H D Gray
Journal:  Cell Death Differ       Date:  2021-08-11       Impact factor: 12.067

Review 7.  Met1-linked ubiquitin signalling in health and disease: inflammation, immunity, cancer, and beyond.

Authors:  Akhee Sabiha Jahan; Camilla Reiter Elbæk; Rune Busk Damgaard
Journal:  Cell Death Differ       Date:  2021-01-13       Impact factor: 12.067

8.  Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death.

Authors:  Justin Taft; Michael Markson; Diana Legarda; Roosheel Patel; Mark Chan; Louise Malle; Ashley Richardson; Conor Gruber; Marta Martín-Fernández; Grazia M S Mancini; Jan A M van Laar; Philomine van Pelt; Sofija Buta; Beatrijs H A Wokke; Ira K D Sabli; Vanessa Sancho-Shimizu; Pallavi Pimpale Chavan; Oskar Schnappauf; Raju Khubchandani; Müşerref Kasap Cüceoğlu; Seza Özen; Daniel L Kastner; Adrian T Ting; Ivona Aksentijevich; Iris H I M Hollink; Dusan Bogunovic
Journal:  Cell       Date:  2021-08-06       Impact factor: 66.850

9.  Site-specific ubiquitination of the E3 ligase HOIP regulates apoptosis and immune signaling.

Authors:  Lilian M Fennell; Carlos Gomez Diaz; Luiza Deszcz; Anoop Kavirayani; David Hoffmann; Kota Yanagitani; Alexander Schleiffer; Karl Mechtler; Astrid Hagelkruys; Josef Penninger; Fumiyo Ikeda
Journal:  EMBO J       Date:  2020-11-20       Impact factor: 14.012

10.  Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target.

Authors:  Lauren Mifflin; Dimitry Ofengeim; Junying Yuan
Journal:  Nat Rev Drug Discov       Date:  2020-07-15       Impact factor: 112.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.